• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

World Tuberculosis Day 2024 theme "Yes! We can end TB" can be made a reality through concerted global efforts that advance detection, diagnosis, and treatment of tuberculosis infection and disease.

作者信息

Goletti Delia, Al-Abri Seif, Migliori Giovanni Battista, Arlehamn Cecilia Lindestam, Haldar Pranabashis, Sundling Christopher, da Costa Christopher, To Kin Wang, Martineau Adrian R, Petersen Eskild, Zumla Alimuddin, Shan Lee Shui

机构信息

Translational Research Unit, Department of Epidemiology and Preclinical Research National Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy.

Royal Hospital, Ministry of Health, Muscat, Oman.

出版信息

Int J Infect Dis. 2024 Apr;141S:106993. doi: 10.1016/j.ijid.2024.106993. Epub 2024 Mar 7.

DOI:10.1016/j.ijid.2024.106993
PMID:38458422
Abstract
摘要

相似文献

1
World Tuberculosis Day 2024 theme "Yes! We can end TB" can be made a reality through concerted global efforts that advance detection, diagnosis, and treatment of tuberculosis infection and disease.2024年世界防治结核病日的主题“是的！我们能终结结核病”可以通过全球共同努力来实现，这些努力旨在推动结核病感染和疾病的检测、诊断及治疗。
Int J Infect Dis. 2024 Apr;141S:106993. doi: 10.1016/j.ijid.2024.106993. Epub 2024 Mar 7.
2
Present-day treatment of tuberculosis and latent tuberculosis infection.当今结核病和潜伏性结核感染的治疗方法。
Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 1:41-6. doi: 10.1016/S0213-005X(11)70017-9.
3
Reactivation tuberculosis: role of surveillance.复发性结核病：监测的作用。
Expert Rev Anti Infect Ther. 2016;14(5):501-9. doi: 10.1586/14787210.2016.1173541.
4
Newer Drugs for Tuberculosis Prevention and Treatment in Children.儿童结核病预防和治疗的新药。
Indian J Pediatr. 2019 Aug;86(8):725-731. doi: 10.1007/s12098-018-02854-8. Epub 2019 Feb 1.
5
Tuberculosis: an overview.结核病：概述
Prim Care. 2013 Sep;40(3):743-56. doi: 10.1016/j.pop.2013.06.003.
6
Serial T-SPOT.TB and quantiFERON-TB-Gold In-Tube assays to monitor response to antitubercular treatment in Italian children with active or latent tuberculosis infection.采用串联 T-SPOT.TB 和 quanTI-FERON-TB-Gold In-Tube 检测监测意大利活动性或潜伏性结核感染患儿抗结核治疗的应答情况。
Pediatr Infect Dis J. 2012 Sep;31(9):974-7. doi: 10.1097/INF.0b013e31825d0d67.
7
Treatment of latent tuberculosis infection.潜伏结核感染的治疗。
Ther Adv Respir Dis. 2013 Dec;7(6):351-6. doi: 10.1177/1753465813503028. Epub 2013 Sep 20.
8
2011: the year in review. part I: tuberculosis.2011 年回顾：结核病篇
Int J Tuberc Lung Dis. 2012 Jun;16(6):740-8. doi: 10.5588/ijtld.12.0139.
9
Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection.潜伏性和亚临床性结核病：感染早期阶段和进展的临床评估。
Clin Microbiol Rev. 2018 Jul 18;31(4). doi: 10.1128/CMR.00021-18. Print 2018 Oct.
10
The Global Landscape of Tuberculosis Therapeutics.全球结核病治疗学全景
Annu Rev Med. 2019 Jan 27;70:105-120. doi: 10.1146/annurev-med-040717-051150. Epub 2018 Nov 7.

引用本文的文献

1
Advancing the fight against tuberculosis: integrating innovation and public health in diagnosis, treatment, vaccine development, and implementation science.推进结核病防治工作：在诊断、治疗、疫苗研发及实施科学方面整合创新与公共卫生。
Front Med (Lausanne). 2025 Aug 25;12:1596579. doi: 10.3389/fmed.2025.1596579. eCollection 2025.
2
Design, synthesis and in silico molecular modelling studies of 2-Hydrazineyl-2-oxoethyl-4-(1H-pyrrol-1-yb) benzoate derivatives: a potent dual DHFR and ENR-reductase inhibitors with antitubercular, antibacterial and cytotoxic potential.2-肼基-2-氧代乙基-4-(1H-吡咯-1-基)苯甲酸酯衍生物的设计、合成及计算机辅助分子模拟研究：一类具有抗结核、抗菌和细胞毒性潜力的高效双功能二氢叶酸还原酶和烯酰还原酶抑制剂
PLoS One. 2025 May 19;20(5):e0323702. doi: 10.1371/journal.pone.0323702. eCollection 2025.
3
Prevalence and Clinical Implications of Pyrazinamide Resistance in Newly Diagnosed TB Patients in Uganda.乌干达新诊断结核病患者中吡嗪酰胺耐药性的患病率及临床意义
Infect Drug Resist. 2025 Mar 29;18:1629-1635. doi: 10.2147/IDR.S491770. eCollection 2025.
4
Specific immune response to and ability to control mycobacterial replication are not impaired in subjects with immune-mediated inflammatory disease and tuberculosis infection.在患有免疫介导的炎症性疾病和结核感染的受试者中，针对分枝杆菌复制的特异性免疫反应及控制能力并未受损。
Front Immunol. 2025 Jan 13;15:1484143. doi: 10.3389/fimmu.2024.1484143. eCollection 2024.
5
Distinguish active tuberculosis with an immune-related signature and molecule subtypes: a multi-cohort analysis.鉴别具有免疫相关特征和分子亚型的活动性结核病：一项多队列分析。
Sci Rep. 2024 Nov 28;14(1):29564. doi: 10.1038/s41598-024-80072-3.
6
Thyroid tuberculosis in women: a scarce phenomenon, with predominancy in women!女性甲状腺结核：一种罕见现象，女性中更为常见！
Rev Assoc Med Bras (1992). 2024 Nov 11;70(10):e20240767. doi: 10.1590/1806-9282.20240767. eCollection 2024.
7
Clinical insights into tuberculosis otitis media: diagnosis, treatment, and management outcomes.中耳结核的临床见解：诊断、治疗及管理结果
Eur Arch Otorhinolaryngol. 2025 Feb;282(2):743-751. doi: 10.1007/s00405-024-08977-3. Epub 2024 Sep 22.
8
Malnutrition and unsuccessful tuberculosis treatment among people with multi-drug resistant tuberculosis in Uganda: A retrospective analysis.乌干达耐多药结核病患者的营养不良与结核病治疗失败：一项回顾性分析
J Clin Tuberc Other Mycobact Dis. 2024 Aug 12;37:100477. doi: 10.1016/j.jctube.2024.100477. eCollection 2024 Dec.
9
Drug resistance profiles of clinical isolates by genotype MTBDRplus line probe assay in Zambia: findings and implications.赞比亚采用MTBDRplus线性探针检测法对临床分离株进行耐药谱分析：结果与意义
JAC Antimicrob Resist. 2024 Jul 25;6(4):dlae122. doi: 10.1093/jacamr/dlae122. eCollection 2024 Aug.